RecruitingNCT07604467

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Effects of CD34+ Stem Cells on Left Ventricular Dysfunction Among Patients With Takotsubo Syndrome


Sponsor

University Medical Centre Ljubljana

Enrollment

40 participants

Start Date

Sep 6, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The underlying mechanisms of microvascular dysfunction in Takotsubo cardiomyopathy remain incompletely understood. As CD34+ cells are essential to coronary microvascular homeostasis we will investigate the potential association between CD34+ cell count and changes in left ventricular function in patients with Takotsubo cardiomyopathy at baseline and 6-month follow-up.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Minimum age 18 years
  • Established TTS per InterTak registry criteria
  • Signed consent form

Exclusion Criteria13

  • Patients under the age of 18 years
  • Ischemic heart disease with at least one complete total occlusion
  • Other concurrent cardiomyopathies
  • Active infectious myocarditis
  • obstructive coronary artery disease
  • Previous hospital stay due to acute coronary syndrome (myocardial infarction) in the last 6 months before TTS acute event
  • Previous interventional coronary artery procedure in the last 6 months before TTS acute event
  • Significant valvular heart disease
  • Significant peripheral artery occlusive disease
  • Active or remitted hematologic malignancy
  • Patients receiving immunosuppressive therapy
  • Significant comorbiditeis affecting patients survival (malignancy)
  • Failure to obtain freely given, informed consent form.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Advanced Heart Failure and Transplantation Program, Department of Cardiology, UMC Ljubljana, Slovenia

Ljubljana, Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07604467


Related Trials